Cellebrite DI (NASDAQ:CLBT) Stock Rating Lowered by Zacks Investment Research

Cellebrite DI (NASDAQ:CLBTGet Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports.

According to Zacks, “Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors. Cellebrite DI Ltd., formerly known as TWC Tech Holdings II Corp., is based in SAN FRANCISCO. “

A number of other research analysts also recently issued reports on CLBT. JPMorgan Chase & Co. assumed coverage on Cellebrite DI in a report on Thursday, February 24th. They set an “overweight” rating and a $10.50 price objective for the company. Needham & Company LLC decreased their price objective on Cellebrite DI from $12.00 to $9.50 and set a “buy” rating for the company in a report on Wednesday, December 29th. Deutsche Bank Aktiengesellschaft increased their price target on Cellebrite DI from $10.50 to $11.00 in a research report on Thursday, February 17th. Finally, Cowen cut their price objective on Cellebrite DI from $20.00 to $17.00 in a research report on Thursday, February 17th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $11.71.

NASDAQ CLBT traded down $0.02 on Tuesday, reaching $5.48. The company had a trading volume of 336,201 shares, compared to its average volume of 306,846. The company has a 50 day moving average of $6.64. Cellebrite DI has a 52 week low of $5.07 and a 52 week high of $13.24.

Cellebrite DI (NASDAQ:CLBTGet Rating) last announced its quarterly earnings results on Wednesday, February 16th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.01. The business had revenue of $67.91 million during the quarter, compared to the consensus estimate of $64.00 million. On average, equities research analysts predict that Cellebrite DI will post 0.17 EPS for the current year.

Several institutional investors and hedge funds have recently modified their holdings of the company. ARK Investment Management LLC bought a new position in shares of Cellebrite DI in the 1st quarter valued at $2,621,000. Yarbrough Capital LLC bought a new position in Cellebrite DI in the 1st quarter valued at approximately $414,000. BlackRock Inc. acquired a new stake in Cellebrite DI during the 4th quarter worth approximately $3,507,000. Goldman Sachs Group Inc. bought a new stake in Cellebrite DI during the 4th quarter worth approximately $177,000. Finally, California State Teachers Retirement System acquired a new position in Cellebrite DI in the 4th quarter valued at approximately $392,000. Institutional investors own 19.13% of the company’s stock.

Cellebrite DI Company Profile (Get Rating)

Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors worldwide. The company offers Cellebrite UFED, a platform for lawfully accessing and collecting digital data; Cellebrite physical analyzer, a digital data examiner; Cellebrite UFED Cloud, a platform that allow to collect, preserve, and analyze public and private-domain, social-media data, instant messaging, file storage, web pages, and other cloud-based content; Cellebrite Frontliner that collects digital evidence in real-time; Cellebrite Responder; and Cellebrite Premium.

Further Reading

Get a free copy of the Zacks research report on Cellebrite DI (CLBT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Cellebrite DI (NASDAQ:CLBT)

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.